L Dang DW White S Gross, et al. 2009 Cancer-associated IDH1 mutations produce 2-hydroxyglutarate Nature 462 739 744 1:CAS:528:DC%2BD1MXhsVGlurzE 10.1038/nature08617 19935646
K Ichimura DM Pearson S Kocialkowski, et al. 2009 IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas Neuro Oncol 11 341 347 1:CAS:528:DC%2BD1MXhtV2qur%2FF 10.1215/15228517-2009-025 19435942
Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis
10.1007/s00401-010-0777-8 21080178
P Metellus B Coulibaly C Colin, et al. 2010 Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis Acta Neuropathol 120 719 729 10.1007/s00401-010-0777-8 21080178
M Sanson Y Marie S Paris, et al. 2009 Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas J Clin Oncol 27 4150 4154 1:CAS:528:DC%2BD1MXhtF2jtLrP 10.1200/JCO.2009.21.9832 19636000
GL Semenza 2010 Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics Oncogene 29 625 634 1:CAS:528:DC%2BD1MXhsV2gt77N 10.1038/onc.2009.441 19946328
H Yan DW Parsons G Jin, et al. 2009 IDH1 and IDH2 mutations in gliomas N Engl J Med 360 765 773 1:CAS:528:DC%2BD1MXitFWru7o%3D 10.1056/NEJMoa0808710 19228619
D Zagzag H Zhong JM Scalzitti E Laughner JW Simons GL Semenza 2000 Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression Cancer 88 2606 2618 1:CAS:528: DC%2BD3cXktFGjsLk%3D 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3. 0.CO;2-W 10861440
S Zhao Y Lin W Xu, et al. 2009 Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1α Science 324 261 265 1:CAS:528:DC%2BD1MXktFals7g%3D 10.1126/science.1170944 19359588